Axogen, Inc.Axogen, Inc.Axogen, Inc.

Axogen, Inc.

No trades
See on Supercharts

AXGN fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Axogen, Inc. engages in the development and market of surgical solutions for peripheral nerve regeneration and repair. It also provides products and education to improve surgical treatment algorithms for peripheral nerve damage or discontinuity. The firm’s products include avance nerve graft, axoguard nerve connector, axoguard nerve protector, avive soft tissue membrane, acroval neurosensory and motor testing system, and axotouch two-point discriminator. The company was founded in 1977 and is headquartered in Alachua, FL.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
AXGN has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company